Interpace Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!

About IDXG

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. 

CEO
Jack E. Stover
CEOJack E. Stover
Employees
89
Employees89
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1986
Founded1986
Employees
89
Employees89

IDXG Key Statistics

Market cap
31.78M
Market cap31.78M
Price-Earnings ratio
0.00
Price-Earnings ratio0.00
Dividend yield
—
Dividend yield—
Average volume
573.44K
Average volume573.44K
High today
$0.92
High today$0.92
Low today
$0.832
Low today$0.832
Open price
$0.92
Open price$0.92
Volume
3.94K
Volume3.94K
52 Week high
$1.12
52 Week high$1.12
52 Week low
$0.381
52 Week low$0.381

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own IDXG. This list is generated using Robinhood data, and it’s not a recommendation.
Motus GI Holdings
Aurora Cannabis
GE
Ford Motor
Nokia
Onconova Therapeutics
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.